|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
DeSantis CE, Ma J, Goding Sauer A, Newman
LA and Jemal A: Breast cancer statistics, 2017, racial disparity in
mortality by state. CA Cancer J Clin. 67:439–448. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Qin C, Zhao Y, Gong C and Yang Z:
MicroRNA-154/ADAM9 axis inhibits the proliferation, migration and
invasion of breast cancer cells. Oncol Lett. 14:6969–6975.
2017.PubMed/NCBI
|
|
5
|
Gehring WJ and Hiromi Y: Homeotic genes
and the homeobox. Annu Rev Genet. 20:147–173. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Scott MP: Vertebrate homeobox gene
nomenclature. Cell. 71:551–553. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yuan C, Zhu X, Han Y, Song C, Liu C, Lu S,
Zhang M, Yu F, Peng Z and Zhou C: Elevated HOXA1 expression
correlates with accelerated tumor cell proliferation and poor
prognosis in gastric cancer partly via cyclin D1. J Exp Clin Cancer
Res. 35:152016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang H, Liu G, Shen D, Ye H, Huang J, Jiao
L and Sun Y: HOXA1 enhances the cell proliferation, invasion and
metastasis of prostate cancer cells. Oncol Rep. 34:1203–1210. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zha TZ, Hu BS, Yu HF, Tan YF, Zhang Y and
Zhang K: Overexpression of HOXA1 correlates with poor prognosis in
patients with hepatocellular carcinoma. Tumour Biol. 33:2125–2134.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Leong AS and Zhuang Z: The changing role
of pathology in breast cancer diagnosis and treatment.
Pathobiology. 78:99–114. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li Y, Lv M, Song Z, Lou Z, Wang R and
Zhuang M: Long non-coding RNA NNT-AS1 affects progression of breast
cancer through miR-142-3p/ZEB1 axis. Biomed Pharmacother.
103:939–946. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li P, Dong J, Zhou X, Sun W, Huang H, Chen
T, Ye B, Zheng Z and Lu M: Expression patterns of microRNA-329 and
its clinical performance in diagnosis and prognosis of breast
cancer. Onco Targets Ther. 10:5711–5718. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Teo WW, Merino VF, Cho S, Korangath P,
Liang X, Wu RC, Neumann NM, Ewald AJ and Sukumar S: HOXA5
determines cell fate transition and impedes tumor initiation and
progression in breast cancer through regulation of E-cadherin and
CD24. Oncogene. 35:5539–5551. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hayashida T, Takahashi F, Chiba N,
Brachtel E, Takahashi M, Godin-Heymann N, Gross KW, Vivanco Md,
Wijendran V, Shioda T, et al: HOXB9, a gene overexpressed in breast
cancer, promotes tumorigenicity and lung metastasis. Proc Natl Acad
Sci USA. 107:1100–1105. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang Y, Yang C, Zhang M, Liu H, Gong C,
Zhang J, Xu S, Zou J, Kai Y and Li Y: Interleukin enhancer-binding
factor 3 and HOXC8 co-activate cadherin 11 transcription to promote
breast cancer cells proliferation and migration. Oncotarget.
8:107477–107491. 2017.PubMed/NCBI
|
|
17
|
Taminiau A, Draime A, Tys J, Lambert B,
Vandeputte J, Nguyen N, Renard P, Geerts D and Rezsöhazy R: HOXA1
binds RBCK1/HOIL-1 and TRAF2 and modulates the TNF/NF-κB pathway in
a transcription-independent manner. Nucleic Acids Res.
44:7331–7349. 2016.PubMed/NCBI
|
|
18
|
Wang JG, Tang WP, Liao MC, Liu YP and Ai
XH: MiR-99a suppresses cell invasion and metastasis in
nasopharyngeal carcinoma through targeting HOXA1. Onco Targets
Ther. 10:753–761. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ni LY, Zhao JD, Lu YH, Li W, Li BL, Wang
XC and Meng QG: MicroRNA-30c suppressed giant-cell tumor of bone
cell metastasis and growth via targeting HOXA1. Eur Rev Med
Pharmacol Sci. 21:4819–4827. 2017.PubMed/NCBI
|
|
20
|
Xiao F, Bai Y, Chen Z, Li Y, Luo L, Huang
J, Yang J, Liao H and Guo L: Downregulation of HOXA1 gene affects
small cell lung cancer cell survival and chemoresistance under the
regulation of miR-100. Eur J Cancer. 50:1541–1554. 2014. View Article : Google Scholar : PubMed/NCBI
|
